Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Maintains Buy on Ocuphire Pharma, Lowers Price Target to $20

HC Wainwright & Co. analyst Matthew Caufield maintains Ocuphire Pharma (NASDAQ:OCUP) with a Buy and lowers the price target from $26 to $20.
byBenzinga Newsdesk
January 26, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

HC Wainwright & Co. analyst Matthew Caufield maintains Ocuphire Pharma (NASDAQ:OCUP) with a Buy and lowers the price target from $26 to $20.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0